Trademark: 79304130
Status Date
Tuesday, August 30, 2022
Registration Number
6829613
Registration Date
Tuesday, August 30, 2022
Filing Date
Tuesday, September 22, 2020
Published for Opposition
Tuesday, June 14, 2022
9 Downloadable software in the nature of mobile application software for medical diagnostics; Downloadable software in the nature of mobile application software for the collection, analysis and reporting of diagnostic tests; downloadable mobile application software for the collection, analysis and reporting of diagnostic tests for Covid-19 and influenza
5 Diagnostic testing materials, namely diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing, medical diagnostic reagents and assays for testing of body fluids, diagnostic agents, preparations and substances for medical purposes; diagnostic materials being diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing, medical diagnostic reagents and assays for testing of body fluids, diagnostic agents, preparations and substances for medical purposes, preparations for medical testing purposes and test strips for medical testing purposes namely for testing for the detection and diagnosis of covid-19 and influenza; diagnostic materials being diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing, medical diagnostic reagents and assays for testing of body fluids, diagnostic agents, preparations and substances for medical purposes, preparations for medical testing purposes and test strips for lateral flow medical testing purposes namely for the detection and diagnosis of covid-19 and influenza; diagnostic reagents for medical purposes; diagnostic testing materials being diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing, medical diagnostic reagents and assays for testing of body fluids, diagnostic agents, preparations and substances for medical purposes for the detection and diagnosis of covid-19 and influenza; diagnostic preparations for medical testing purposes; materials namely diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing, medical diagnostic reagents and assays for testing of body fluids, diagnostic agents, preparations and substances for medical purposes, and medical diagnostic strips for lateral flow medical testing purposes namely for the detection and diagnosis of covid-19 and influenza, and diagnostic reagents for medical testing purposes, all for the detection and diagnosis of covid-19 and influenza
44 Medical diagnostic testing being medical testing for diagnostic or treatment purposes, and analysis services namely medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical testing being medical testing for diagnostic or treatment purposes, and analysis services namely medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical diagnostic testing being medical testing for diagnostic or treatment purposes, and analysis services namely medical analysis services for diagnostic and treatment purposes provided by medical laboratories for covid-19 and influenza; medical testing being medical testing for diagnostic or treatment purposes and analysis services namely medical analysis services for diagnostic and treatment purposes provided by medical laboratories for covid-19 and influenza; advisory and information services relating to all the aforesaid
10 Medical testing apparatus, instruments and equipment for diagnostic use namely apparatus for medical diagnostic testing for the detection and diagnosis of covid-19 and influenza; medical testing apparatus, instruments and equipment for the detection and diagnosis of Covid-19 and influenza, namely medical diagnostic apparatus for testing for viruses, medical diagnostic instruments for the analysis of body fluids, apparatus for virus testing purposes
Dec 28, 2022
Final Decision Transaction Processed By Ib
Dec 7, 2022
Final Disposition Notice Sent To Ib
Dec 7, 2022
Final Disposition Processed
Nov 30, 2022
Final Disposition Notice Created, To Be Sent To Ib
Aug 30, 2022
Notice Of Registration Confirmation Emailed
Aug 30, 2022
Registered-Principal Register
Aug 1, 2022
Notification Of Possible Opposition - Processed By Ib
Jul 13, 2022
Notification Of Possible Opposition Sent To Ib
Jul 13, 2022
Notification Of Possible Opposition Created, To Be Sent To Ib
Jul 5, 2022
Notification Processed By Ib
Jun 14, 2022
Official Gazette Publication Confirmation E-Mailed
Jun 14, 2022
Published For Opposition
Jun 8, 2022
Notification Of Possible Opposition Sent To Ib
Jun 8, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
May 25, 2022
Notification Of Notice Of Publication E-Mailed
May 9, 2022
Approved For Pub - Principal Register
May 9, 2022
Notification Of Non-Final Action E-Mailed
May 9, 2022
Non-Final Action E-Mailed
May 9, 2022
Non-Final Action Written
May 2, 2022
Suspension Checked ¿ To Attorney For Action
Apr 18, 2022
Teas/Email Correspondence Entered
Apr 18, 2022
Correspondence Received In Law Office
Apr 18, 2022
Teas Response To Suspension Inquiry Received
Aug 31, 2021
Notification Of Letter Of Suspension E-Mailed
Aug 31, 2021
Letter Of Suspension E-Mailed
Aug 31, 2021
Suspension Letter Written
Aug 4, 2021
Teas/Email Correspondence Entered
Aug 4, 2021
Correspondence Received In Law Office
Aug 4, 2021
Teas Response To Office Action Received
Mar 15, 2021
Refusal Processed By Ib
Feb 22, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Feb 22, 2021
Refusal Processed By Mpu
Feb 16, 2021
Application Filing Receipt Mailed
Feb 13, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Feb 12, 2021
Non-Final Action Written
Feb 12, 2021
Assigned To Examiner
Feb 12, 2021
New Application Office Supplied Data Entered In Tram
Feb 11, 2021
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
